Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohort

Author:

van Stigt Arthur H.,Oude Rengerink Katrien,Bloemenkamp Kitty W. M.,de Waal Wouter,Prevaes Sabine M. P. J.,Le Thuy-My,van Wijk Femke,Nederend Maaike,Hellinga Anneke H.,Lammers Christianne S.,den Hartog Gerco,van Herwijnen Martijn J. C.,Garssen Johan,Knippels Léon M. J.,Verhagen Lilly M.,de Theije Caroline G. M.,Lopez-Rincon Alejandro,Leusen Jeanette H. W.,van’t Land Belinda,Bont Louis,Knulst André C.,van der Ent C. Kors,van Baarle Debbie,Wauben Marca H. M.,Rots Nynke Y.,Sanders Elisabeth A. M.,Benders Manon J. N. L.,Meulenbroek Laura A. M. P.,Stahl Bernd,Kraneveld Aletta D.,Buiteman Brigitte J. M.,Voogt Tanja,van der Meij Barbara,Lerkvaleekul Butsabong,Voogd Eline,Lammers Christianne S.,Lalmahomed Tariq A.,Brus Iris M.,van Meerwijk Daphne M. M.,Jepma Sophie I. E.,

Abstract

Abstract Background Many studies support the protective effect of breastfeeding on respiratory tract infections. Although infant formulas have been developed to provide adequate nutritional solutions, many components in human milk contributing to the protection of newborns and aiding immune development still need to be identified. In this paper we present the methodology of the “Protecting against Respiratory tract lnfections through human Milk Analysis” (PRIMA) cohort, which is an observational, prospective and multi-centre birth cohort aiming to identify novel functions of components in human milk that are protective against respiratory tract infections and allergic diseases early in life. Methods For the PRIMA human milk cohort we aim to recruit 1000 mother–child pairs in the first month postpartum. At one week, one, three, and six months after birth, fresh human milk samples will be collected and processed. In order to identify protective components, the level of pathogen specific antibodies, T cell composition, Human milk oligosaccharides, as well as extracellular vesicles (EVs) will be analysed, in the milk samples in relation to clinical data which are collected using two-weekly parental questionnaires. The primary outcome of this study is the number of parent-reported medically attended respiratory infections. Secondary outcomes that will be measured are physician diagnosed (respiratory) infections and allergies during the first year of life. Discussion The PRIMA human milk cohort will be a large prospective healthy birth cohort in which we will use an integrated, multidisciplinary approach to identify the longitudinal effect human milk components that play a role in preventing (respiratory) infections and allergies during the first year of life. Ultimately, we believe that this study will provide novel insights into immunomodulatory components in human milk. This may allow for optimizing formula feeding for all non-breastfed infants.

Funder

Nutricia Research Foundation

Universitair Medisch Centrum Utrecht

Ministerie van Volksgezondheid, Welzijn en Sport

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3